Literature DB >> 21653724

Impaired sensory nerve function and axon morphology in mice with diabetic neuropathy.

Richard C Lennertz1, Karen A Medler, James L Bain, Douglas E Wright, Cheryl L Stucky.   

Abstract

Diabetes is the most prevalent metabolic disorder in the United States, and between 50% and 70% of diabetic patients suffer from diabetes-induced neuropathy. Yet our current knowledge of the functional changes in sensory nerves and their distal terminals caused by diabetes is limited. Here, we set out to investigate the functional and morphological consequences of diabetes on specific subtypes of cutaneous sensory nerves in mice. Diabetes was induced in C57Bl/6 mice by a single intraperitoneal injection of streptozotocin. After 6-8 wk, mice were characterized for behavioral sensitivity to mechanical and heat stimuli followed by analysis of sensory function using teased nerve fiber recordings and histological assessment of nerve fiber morphology. Diabetes produced severe functional impairment of C-fibers and rapidly adapting Aβ-fibers, leading to behavioral hyposensitivity to both mechanical and heat stimuli. Electron microscopy images showed that diabetic nerves have axoplasm with more concentrated organelles and frequent axon-myelin separations compared with control nerves. These changes were restricted to the distal nerve segments nearing their innervation territory. Furthermore, the relative proportion of Aβ-fibers was reduced in diabetic skin-nerve preparations compared with nondiabetic control mice. These data identify significant deficits in sensory nerve terminal function that are associated with distal fiber loss, morphological damage, and behavioral hyposensitivity in diabetic C57Bl/6 mice. These findings suggest that diabetes damages sensory nerves, leading to functional deficits in sensory signaling that underlie the loss of tactile acuity and pain sensation associated with insensate diabetic neuropathy.

Entities:  

Mesh:

Year:  2011        PMID: 21653724      PMCID: PMC3154824          DOI: 10.1152/jn.01123.2010

Source DB:  PubMed          Journal:  J Neurophysiol        ISSN: 0022-3077            Impact factor:   2.714


  48 in total

1.  Tissue glucose level modulates the mechanical responses of cutaneous nociceptors in streptozotocin-diabetic rats but not normal rats in vitro.

Authors:  Yoshiaki Suzuki; Jun Sato; Minoru Kawanishi; Kazue Mizumura
Journal:  Pain       Date:  2002-10       Impact factor: 6.961

2.  Inducible nitric oxide synthase gene deficiency counteracts multiple manifestations of peripheral neuropathy in a streptozotocin-induced mouse model of diabetes.

Authors:  I Vareniuk; I A Pavlov; I G Obrosova
Journal:  Diabetologia       Date:  2008-09-19       Impact factor: 10.122

3.  [Diabetes mellitus and its degenerative complications: a prospective study of 4,400 patients observed between 1947 and 1973 (author's transl)].

Authors:  J Pirart
Journal:  Diabete Metab       Date:  1977-06

4.  Overexpression of nerve growth factor in skin selectively affects the survival and functional properties of nociceptors.

Authors:  C L Stucky; M Koltzenburg; M Schneider; M G Engle; K M Albers; B M Davis
Journal:  J Neurosci       Date:  1999-10-01       Impact factor: 6.167

5.  Axo-glial dysjunction. A novel structural lesion that accounts for poorly reversible slowing of nerve conduction in the spontaneously diabetic bio-breeding rat.

Authors:  A A Sima; S A Lattimer; S Yagihashi; D A Greene
Journal:  J Clin Invest       Date:  1986-02       Impact factor: 14.808

6.  Cutaneous innervation in sensory neuropathies: evaluation by skin biopsy.

Authors:  B G McCarthy; S T Hsieh; A Stocks; P Hauer; C Macko; D R Cornblath; J W Griffin; J C McArthur
Journal:  Neurology       Date:  1995-10       Impact factor: 9.910

7.  Projection of the year 2050 burden of diabetes in the US adult population: dynamic modeling of incidence, mortality, and prediabetes prevalence.

Authors:  James P Boyle; Theodore J Thompson; Edward W Gregg; Lawrence E Barker; David F Williamson
Journal:  Popul Health Metr       Date:  2010-10-22

8.  Quantitative assessment of tactile allodynia in the rat paw.

Authors:  S R Chaplan; F W Bach; J W Pogrel; J M Chung; T L Yaksh
Journal:  J Neurosci Methods       Date:  1994-07       Impact factor: 2.390

9.  Streptozocin-induced diabetic rats: behavioural evidence for a model of chronic pain.

Authors:  C Courteix; A Eschalier; J Lavarenne
Journal:  Pain       Date:  1993-04       Impact factor: 6.961

10.  Reduced levels of mRNA encoding endoskeletal and growth-associated proteins in sensory ganglia in experimental diabetes.

Authors:  L Mohiuddin; P Fernyhough; D R Tomlinson
Journal:  Diabetes       Date:  1995-01       Impact factor: 9.461

View more
  20 in total

1.  Reducing monocarboxylate transporter MCT1 worsens experimental diabetic peripheral neuropathy.

Authors:  Mithilesh Kumar Jha; Xanthe H Ament; Fang Yang; Ying Liu; Michael J Polydefkis; Luc Pellerin; Brett M Morrison
Journal:  Exp Neurol       Date:  2020-07-25       Impact factor: 5.330

Review 2.  Diabetic peripheral neuropathy: should a chaperone accompany our therapeutic approach?

Authors:  Kevin L Farmer; Chengyuan Li; Rick T Dobrowsky
Journal:  Pharmacol Rev       Date:  2012-08-10       Impact factor: 25.468

Review 3.  Schwann cell interactions with axons and microvessels in diabetic neuropathy.

Authors:  Nádia P Gonçalves; Christian B Vægter; Henning Andersen; Leif Østergaard; Nigel A Calcutt; Troels S Jensen
Journal:  Nat Rev Neurol       Date:  2017-01-30       Impact factor: 42.937

Review 4.  Dysfunctional Sensory Modalities, Locus Coeruleus, and Basal Forebrain: Early Determinants that Promote Neuropathogenesis of Cognitive and Memory Decline and Alzheimer's Disease.

Authors:  Mak Adam Daulatzai
Journal:  Neurotox Res       Date:  2016-06-23       Impact factor: 3.911

Review 5.  The metabolic syndrome and neuropathy: therapeutic challenges and opportunities.

Authors:  Brian Callaghan; Eva Feldman
Journal:  Ann Neurol       Date:  2013-09       Impact factor: 10.422

6.  Coenzyme Q10 prevents peripheral neuropathy and attenuates neuron loss in the db-/db- mouse, a type 2 diabetes model.

Authors:  Tie-Jun Sten Shi; Ming-Dong Zhang; Hugo Zeberg; Johanna Nilsson; Jacob Grünler; Su-Xing Liu; Qiong Xiang; Jonas Persson; Kaj J Fried; Sergiu Bogdan Catrina; Masahiko Watanabe; Peter Arhem; Kerstin Brismar; Tomas G M Hökfelt
Journal:  Proc Natl Acad Sci U S A       Date:  2012-12-24       Impact factor: 11.205

7.  Sensory neuropathy hampers nociception-mediated bone marrow stem cell release in mice and patients with diabetes.

Authors:  Zexu Dang; Davide Maselli; Gaia Spinetti; Elena Sangalli; Franco Carnelli; Francesco Rosa; Elena Seganfreddo; Fabio Canal; Anna Furlan; Agostino Paccagnella; Emanuela Paiola; Bruno Lorusso; Claudia Specchia; Mattia Albiero; Roberta Cappellari; Angelo Avogaro; Angela Falco; Federico Quaini; Kepeng Ou; Iker Rodriguez-Arabaolaza; Costanza Emanueli; Maria Sambataro; Gian Paolo Fadini; Paolo Madeddu
Journal:  Diabetologia       Date:  2015-09-10       Impact factor: 10.122

8.  The co-occurrence of myocardial dysfunction and peripheral insensate neuropathy in a streptozotocin-induced rat model of diabetes.

Authors:  Maria N Marangoni; Scott T Brady; Shamim A Chowdhury; Mariann R Piano
Journal:  Cardiovasc Diabetol       Date:  2014-01-11       Impact factor: 9.951

9.  High energy diets-induced metabolic and prediabetic painful polyneuropathy in rats.

Authors:  Fang Xie; Han Fu; Jun-Feng Hou; Kai Jiao; Michael Costigan; Jun Chen
Journal:  PLoS One       Date:  2013-02-25       Impact factor: 3.240

10.  Mechanical sensitization of cutaneous sensory fibers in the spared nerve injury mouse model.

Authors:  Amanda K Smith; Crystal L O'Hara; Cheryl L Stucky
Journal:  Mol Pain       Date:  2013-11-29       Impact factor: 3.395

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.